MichaelAnthonyMcDevittMD

PubMed

• 22 citations
  Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors
  Jason J. Luke, Fabrice Barlesi, Ki Y. Chung, Anthony W. Tolcher, Karen Kelly, Antoine Hollebecque, Christophe Le Tourneau, Vivek Subbiah, Frank Tsai, Steven Kao, Phili...> ;Journal for Immunotherapy of Cancer. 2021 Feb 1
• 8 citations
  Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat.
  Elisabeth Oppliger Leibundgut, Monika Haubitz, Bart Burington, Oliver G. Ottmann, Gary Spitzer, Olatoyosi Odenike, Michael A. McDevitt, Alexander Röth, David S. Snyder...> ;Haematologica. 2020 Jul 30
• 10 citations
  BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies
  Weijie Poh, Robert L. Dilley, Alison R. Moliterno, Jaroslaw P. Maciejewski, Keith W. Pratz, Michael A. McDevitt, James G. Herman> ;Clinical Cancer Research. 2019 Apr 15
• 48 citations
  A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia.
  Ivana Gojo, Jan H. Beumer, Keith W. Pratz, Michael A. McDevitt, Maria R. Baer, Amanda L. Blackford, B. Douglas Smith, Steven D. Gore, Hetty E. Carraway, Margaret M. Sh...> ;Clinical Cancer Research. 2017 Feb 1
• 32 citations
  A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leuk...
  Keith W. Pratz, Michelle A. Rudek, Ivana Gojo, Mark R. Litzow, Michael A. McDevitt, Jiuping Ji, Larry M. Karnitz, James G. Herman, Robert J. Kinders, B. Douglas Smith,...> ;Clinical Cancer Research. 2017 Feb 15
• 10 citations
  Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature
  Kelly J. Norsworthy, Amy E. DeZern, Hua Ling Tsai, Wesley Hand, Ravi Varadhan, Steven D. Gore, Ivana Gojo, Keith W. Pratz, Hetty E. Carraway, Margaret M. Showel, Micha...> ;Leukemia Research. 2017 Oct 1
• 35 citations
  Recurrent genetic defects on chromosome 5q in myeloid neoplasms
  Naoko Hosono, Hideki Makishima, Reda Z. Mahfouz, Bartlomiej P Przychodzen, Kenichi Yoshida, Andres Jerez, Thomas LaFramboise, Chantana Polprasert, Michael J. Clemente,...> ;Oncotarget. 2017 Jan 24
• 21 citations
  Poly(ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms
  Keith W. Pratz, Brian D. Koh, Anand G. Patel, Karen S. Flatten, Weijie Poh, James G. Herman, Robert L. Dilley, Maria I. Harrell, B. Douglas Smith, Judith E. Karp, Eliz...> ;Clinical Cancer Research. 2016 Aug 1
• 141 citations
  Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia
  Gabriela M. Baerlocher, Elisabeth Oppliger Leibundgut, Oliver G. Ottmann, Gary Spitzer, Olatoyosi Odenike, Michael A. McDevitt, Alexander Röth, Michael Daskalakis, Bar...> ;The New England Journal of Medicine. 2015 Sep 2
• 180 citations
  Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
  Yvette L. Kasamon, Javier Bolaños-Meade, Gabrielle T. Prince, Hua Ling Tsai, Shannon R. McCurdy, Jennifer A. Kanakry, Gary L. Rosner, Robert A. Brodsky, Karlo Perica, ...> ;Journal of Clinical Oncology. 2015 Aug 10
• Erratum for Elagib et al., Jun Blockade of Erythropoiesis: Role for Repression of GATA-1 by HERP2.
  Kamaleldin E. Elagib, Mang Xiao, Isa M. Hussaini, Lorrie L. Delehanty, Lisa A. Palmer, Frederick Racke, Michael J. Birrer, Shanmugasundaram Ganapathy-Kanniappan, Micha...> ;Molecular and Cellular Biology. 2015 Jun 15
• 222 citations
  Risk-stratified outcomes of nonmyeloablative, HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
  Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel, Hua Ling Tsai, Javier Bolaños-Meade, Gary L. Rosner, Christopher G. Kanakry, Karlo Perica, Heather J. Symo...> ;Blood. 2015 May 7
• 85 citations
  Correction to A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia [The Journal of Experimental Medicine...
  Michael A. McDevitt, Jianlin Xie, Shanmugasundaram Ganapathy-Kanniappan, Jason W. Griffith, Aihua Liu, Courtney McDonald, Philip E. Thuma, Victor R. Gordeuk, Christine...> ;The Journal of Experimental Medicine. 2015 May 4
• 146 citations
  Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
  Christopher G. Kanakry, Hua Ling Tsai, Javier Bolaños-Meade, B. Douglas Smith, Ivana Gojo, Jennifer A. Kanakry, Yvette L. Kasamon, Douglas E. Gladstone, William Matsui...> ;Blood. 2014 Dec 11
• 42 citations
  A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms.
  Joshua F. Zeidner, Judith E. Karp, Amanda L. Blackford, B. Douglas Smith, Ivana Gojo, Steven D. Gore, Mark J. Levis, Hetty E. Carraway, Jacqueline Greer, S. Percy Ivy,...> ;Haematologica. 2014 Apr 1
• 7 citations
  Poly(ADP-ribose) polymerase inhibitor CEP-8983 synergizes with bendamustine in chronic lymphocytic leukemia cells in vitro.
  Robert L. Dilley, Weijie Poh, Douglas E. Gladstone, James G. Herman, Margaret M. Showel, Judith E. Karp, Michael A. McDevitt, Keith W. Pratz> ;Leukemia Research. 2014 Mar 1
• 37 citations
  Recurrent genetic defects on chromosome 7q in myeloid neoplasms
  Naoko Hosono, Hideki Makishima, Andres Jerez, Kenichi Yoshida, Bartlomiej P Przychodzen, Sarah McMahon, Yuichi Shiraishi, Kenichi Chiba, Hirokazu Tanaka, Satoru Miyano...> ;Leukemia. 2014 Jan 16
• 26 citations
  Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling.
  Hrishikesh M. Mehta, Taly Glaubach, A. Long, Hannah Lu, Bartlomiej P Przychodzen, Hideki Makishima, Michael A. McDevitt, Nicholas C.P. Cross, Jaroslaw P. Maciejewski, ...> ;Leukemia. 2013 Jun 6
• 45 citations
  Novel recurrent mutations in the RAS -like GTP-binding gene RIT1 in myeloid malignancies
  Inés Gómez-Seguí, Hideki Makishima, Andres Jerez, Kenichi Yoshida, Bartlomiej P Przychodzen, Satoru Miyano, Yuichi Shiraishi, Holleh D Husseinzadeh, Kathryn M Guinta, ...> ;Leukemia. 2013 Sep 1
• 8 citations
  Burst-forming unit-erythroid assays to distinguish cellular bone marrow failure disorders.
  Amy E. DeZern, Jeffrey J. Pu, Michael A. McDevitt, Richard J. Jones, Robert A. Brodsky> ;Experimental Hematology. 2013 Sep 1
• 194 citations
  Somatic SETBP1 mutations in myeloid malignancies
  Hideki Makishima, Kenichi Yoshida, Nhu Nguyen, Bartlomiej P Przychodzen, Masashi Sanada, Yusuke Okuno, Kwok Peng Ng, Kristbjorn O. Gudmundsson, Bandana A. Vishwakarma,...> ;Nature Genetics. 2013 Aug 1
• 108 citations
  Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies
  Shahper N. Khan, Anna M. Jankowska, Reda Z. Mahfouz, Andrew Dunbar, Yuka Sugimoto, Naoko Hosono, Zhenbo Hu, Venugopalan Cheriyath, Sergei Vatolin, Bartlomiej P Przycho...> ;Leukemia. 2013 Jun 1
• Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms.
  Nischal S, Bhattacharyya S, Christopeit M, Yu Y, Zhou L, Bhagat TD, Sohal D, Will B, Mo Y, Suzuki M, Pardanani A, McDevitt M, Maciejewski JP, Melnick AM, Greally JM, S...> ;Cancer Res.. 2013-02-01
• 64 citations
  Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leu...
  Sarah Abu Kar, Anna M. Jankowska, Hideki Makishima, Valeria Visconte, Andres Jerez, Yuka Sugimoto, Hideki Muramatsu, Fabiola Traina, Manuel G. Afable, Kathryn M Guinta...> ;Haematologica. 2013 Jan 1
• 89 citations
  Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias
  Judith E. Karp, Brian M. Thomas, Jacqueline Greer, Christopher Sorge, Steven D. Gore, Keith W. Pratz, B. Douglas Smith, Karen S. Flatten, Kevin A. Peterson, Paula A. S...> ;Clinical Cancer Research. 2012 Dec 15
• Join now to see all